Webinar | From Concept to Prototype:
The Cold Atmospheric Pressure Plasma Platform Developed for Minimally Invasive Cancer Treatment
WHEN
29 September 2026 — 17:00 EEST | 10:00 EDT
Approximately 50–60 minutes, including live Q&A.
This session is designed for researchers, biomedical engineers and clinicians with an interest in plasma medicine, as well as medtech innovators and stakeholders in the EIC ecosystem curious about plasma medicine and new technologies in cancer treatment.
IgnitePLASMA is funded by the European Innovation Council (EIC) under the Pathfinder Open programme (Grant Agreement No. 101129853) and UKRI (Grant Agreement No. 10106237).
Disclaimer:
By registering, you agree that Synnous Ltd may process the details you provide in order to administer this webinar and to report attendance figures to the European Innovation Council and UKRI, as required under the IgnitePLASMA grant agreements.This section will be recorded for internal project purposes. Attendee cameras and microphones remain off throughout; however, the name you register with may be visible if you submit a question during the Q&A.
To ask how your data is handled, or to request its deletion, contact us via igniteplasma.eu.
Pancreatic and biliary tract cancers remain among the most difficult cancers to treat, with limited surgical options and survival rates that have changed little in decades. Cold atmospheric pressure plasma (CAPP) is emerging as a promising modality, offering selective cytotoxic effects on tumour cells while minimising damage to surrounding healthy tissue.
Within the EIC- and UKRI-funded IgnitePLASMA project, researchers at the University of Patras have been designing, building and characterising the CAPP hardware platform that will underpin a novel minimally invasive surgical tool targeting these two malignancies.
Dr. Panagiotis Svarnas, Professor, University of Patras, Greece, leading its design and development, will present the engineering journey: from design requirements and plasma source development — including sinusoidal and pulsed CAPP configurations — through to sensor integration and the adaptive treatment capabilities now being refined. A demonstration of the 4D programmable translation stage system will offer a concrete look at the platform in action.
SPEAKERS
Dr. Panagiotis Svarnas, Professor, University of Patras, GR
Dr Vasileios Vavourakis, Professor, University of Cyprus
Register here
WHEN
29 September 2026 — 17:00 EEST | 10:00 EDT
Approximately 50–60 minutes, including live Q&A.
This session is designed for researchers, biomedical engineers and clinicians with an interest in plasma medicine, as well as medtech innovators and stakeholders in the EIC ecosystem curious about plasma medicine and new technologies in cancer treatment.
IgnitePLASMA is funded by the European Innovation Council (EIC) under the Pathfinder Open programme (Grant Agreement No. 101129853) and UKRI (Grant Agreement No. 10106237).
Disclaimer:
By registering, you agree that Synnous Ltd may process the details you provide in order to administer this webinar and to report attendance figures to the European Innovation Council and UKRI, as required under the IgnitePLASMA grant agreements.This section will be recorded for internal project purposes. Attendee cameras and microphones remain off throughout; however, the name you register with may be visible if you submit a question during the Q&A.
To ask how your data is handled, or to request its deletion, contact us via igniteplasma.eu.
